Literature DB >> 11408806

Establishment and characterization of a new cell line (SKS) from neuroendocrine small cell carcinoma of the uterine cervix and its chemosensitivity.

Y Saga1, M Suzuki, N Tamura, M Ohwada, I Sato.   

Abstract

A new cell line (SKS) established from ascites of a patient with neuroendocrine small cell carcinoma of the uterine cervix had a good tumorigenicity and caused marked peritoneal dissemination, and was also highly sensitive to gemcitabine in an in vitro chemosensitivity test. SKS cells were small round cells with a high nuclear/cytoplasmic (N/C) ratio and grew into colony-like aggregates, forming spherical aggregates of floating cells. The population doubling time was 44 h. The number of chromosomes ranged from 50 to 56. On examination of the ultrastructure, membrane-bound dense-core neurosecretory-type granules were observed in the cytoplasm. Neuron-specific enolase (NSE) was immunocytochemically positive in the cytoplasm, and 9.3 ng/ml of NSE was detected in the cell culture supernatant. Human papillomavirus was not detected. In the p53 gene, a 3-bp deletion, AAC (Asn), was detected at codon 131 in exon 5. SKS exhibited good tumorigenicity, and the tumor doubling time was 11 days. Intraperitoneal injection of the cells caused peritoneal dissemination, and marked ascites formation was observed. SKS was highly sensitive to gemcitabine, and the 50% growth inhibitory concentration was 30 nM. SKS cells are useful as a model of neuroendocrine small cell carcinoma of the cervix, and chemotherapy using gemcitabine may possibly be effective in this malignancy. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408806     DOI: 10.1159/000058534

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  2 in total

1.  Characterization of a TP53 Somatic Variant of Unknown Function From an Ovarian Cancer Patient Using Organoid Culture and Computational Modeling.

Authors:  Jianling Bi; Kristina W Thiel; Jacob M Litman; Yuping Zhang; Eric J Devor; Andreea M Newtson; Michael J Schnieders; Jesus Gonzalez Bosquet; Kimberly K Leslie
Journal:  Clin Obstet Gynecol       Date:  2020-03       Impact factor: 1.966

2.  PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line.

Authors:  Zih-Yin Lai; Hsin-Yueh Yeo; Ya-Tse Chen; Kuo-Ming Chang; Tze-Chien Chen; Yung-Jen Chuang; Shing-Jyh Chang
Journal:  Oncotarget       Date:  2017-07-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.